Lysophosphatidylethanolamine Improves Diastolic Dysfunction by Alleviating Mitochondrial Injury in the Aging Heart

Overview

Journal J Lipid Res

Publisher Elsevier

Specialty Biochemistry

Date 2024 Nov 23

PMID 39579983

Authors

Guiwen Xu

Wei Xiao

Pengqi Sun

Yuanjun Sun

Xinyu Yang

Xiaomeng Yin

Yang Liu

Affiliations

Soon will be listed here.

Abstract

Diastolic dysfunction in aging mice is linked to mitochondrial abnormalities, including mitochondrial morphology disorders and decreases in membrane potential. Studies also show that aberrant mitochondrial lipid metabolism impairs mitochondrial function in aging cardiomyocytes. Our lipidomic analysis revealed that phosphatidylethanolamine (PE) levels were significantly decreased in aging myocardial mitochondria. Here, we investigated whether a reduction in PE levels in myocardial mitochondria contributes to mitochondrial injury as well as HFpEF pathogenesis and whether modulation of PE levels could ameliorate aging-induced HFpEF. Echocardiography was used to assess cardiac diastolic function in adult and aging mice treated with lysophosphatidylethanolamine (LPE) or saline. Mitochondrial morphologies from tissue samples were evaluated by transmission electron microscopy (TEM), while mitochondrial membrane potential and reactive oxygen species (ROS) levels were assessed using JC-1, MitoSOX, and DCFH-DA detection assays. We performed GO enrichment analysis between adult and aging mice and discovered significant enrichment in transcriptional programs associated with mitochondria and lipid metabolism. Also, mitochondrial PE levels were significantly decreased in aging cardiomyocytes. Treatment with LPE (200 μg/kg) significantly enhanced PE content in aging mice and improved the structure of mitochondria in cardiac cells. Also, LPE treatment protects against aging-induced deterioration of mitochondrial injury, as evidenced by increased mitochondrial membrane potential and decreased mitochondrial ROS. Furthermore, treatment with LPE alleviated severe diastolic dysfunction in aging mice. Taken together, our results suggest that LPE treatment enhances PE levels in mitochondria and ameliorates aging-induced diastolic dysfunction in mice through a mechanism involving improved mitochondrial structure and function.

References

Pfeffer M, Shah A, Borlaug B . Heart Failure With Preserved Ejection Fraction In Perspective. Circ Res. 2019; 124(11):1598-1617. PMC: 6534165. DOI: 10.1161/CIRCRESAHA.119.313572. View

Papsdorf K, Brunet A . Linking Lipid Metabolism to Chromatin Regulation in Aging. Trends Cell Biol. 2018; 29(2):97-116. PMC: 6340780. DOI: 10.1016/j.tcb.2018.09.004. View

Brown D, Perry J, Allen M, Sabbah H, Stauffer B, Shaikh S . Expert consensus document: Mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol. 2016; 14(4):238-250. PMC: 5350035. DOI: 10.1038/nrcardio.2016.203. View

Poznyak A, Kirichenko T, Borisov E, Shakhpazyan N, Kartuesov A, Orekhov A . Mitochondrial Implications in Cardiovascular Aging and Diseases: The Specific Role of Mitochondrial Dynamics and Shifts. Int J Mol Sci. 2022; 23(6). PMC: 8949229. DOI: 10.3390/ijms23062951. View

van Meer G, Voelker D, Feigenson G . Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008; 9(2):112-24. PMC: 2642958. DOI: 10.1038/nrm2330. View

Colina-Tenorio L, Horten P, Pfanner N, Rampelt H . Shaping the mitochondrial inner membrane in health and disease. J Intern Med. 2020; 287(6):645-664. DOI: 10.1111/joim.13031. View

St Germain M, Iraji R, Bakovic M . Phosphatidylethanolamine homeostasis under conditions of impaired CDP-ethanolamine pathway or phosphatidylserine decarboxylation. Front Nutr. 2023; 9:1094273. PMC: 9849821. DOI: 10.3389/fnut.2022.1094273. View

Liu X, Hartman C, Li L, Albert C, Si F, Gao A . Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy. Sci Transl Med. 2021; 13(587. DOI: 10.1126/scitranslmed.aaz6314. View

Yamamoto Y, Sakurai T, Chen Z, Inoue N, Chiba H, Hui S . Lysophosphatidylethanolamine Affects Lipid Accumulation and Metabolism in a Human Liver-Derived Cell Line. Nutrients. 2022; 14(3). PMC: 8839386. DOI: 10.3390/nu14030579. View

10.

Steenbergen R, Nanowski T, Beigneux A, Kulinski A, Young S, Vance J . Disruption of the phosphatidylserine decarboxylase gene in mice causes embryonic lethality and mitochondrial defects. J Biol Chem. 2005; 280(48):40032-40. PMC: 2888304. DOI: 10.1074/jbc.M506510200. View

11.

Kennedy E, Weiss S . The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem. 1956; 222(1):193-214. View

12.

Erchova I, Sun S, Votruba M . A Perspective on Accelerated Aging Caused by the Genetic Deficiency of the Metabolic Protein, OPA1. Front Neurol. 2021; 12:641259. PMC: 8076550. DOI: 10.3389/fneur.2021.641259. View

13.

Tamura Y, Sesaki H, Endo T . Phospholipid transport via mitochondria. Traffic. 2014; 15(9):933-45. PMC: 4140972. DOI: 10.1111/tra.12188. View

14.

Ngo J, Choi D, Stanley I, Stiles L, Molina A, Chen P . Mitochondrial morphology controls fatty acid utilization by changing CPT1 sensitivity to malonyl-CoA. EMBO J. 2023; 42(11):e111901. PMC: 10233380. DOI: 10.15252/embj.2022111901. View

15.

Matyash V, Liebisch G, Kurzchalia T, Shevchenko A, Schwudke D . Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res. 2008; 49(5):1137-46. PMC: 2311442. DOI: 10.1194/jlr.D700041-JLR200. View

16.

Dai D, Rabinovitch P, Ungvari Z . Mitochondria and cardiovascular aging. Circ Res. 2012; 110(8):1109-24. PMC: 3867977. DOI: 10.1161/CIRCRESAHA.111.246140. View

17.

Sawyer D, Siwik D, Xiao L, Pimentel D, Singh K, Colucci W . Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol. 2002; 34(4):379-88. DOI: 10.1006/jmcc.2002.1526. View

18.

Zhao T, Goedhart C, Sam P, Sabouny R, Lingrell S, Cornish A . is a mitochondrial disease gene causing skeletal dysplasia, cataracts, and white matter changes. Life Sci Alliance. 2019; 2(2). PMC: 6412922. DOI: 10.26508/lsa.201900353. View

19.

Fullerton M, Hakimuddin F, Bakovic M . Developmental and metabolic effects of disruption of the mouse CTP:phosphoethanolamine cytidylyltransferase gene (Pcyt2). Mol Cell Biol. 2007; 27(9):3327-36. PMC: 1899976. DOI: 10.1128/MCB.01527-06. View

20.

Hishikawa D, Shindou H, Kobayashi S, Nakanishi H, Taguchi R, Shimizu T . Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity. Proc Natl Acad Sci U S A. 2008; 105(8):2830-5. PMC: 2268545. DOI: 10.1073/pnas.0712245105. View